1-5 of 5
Thomas A. Gardner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

Noah M. Hahn, Trinity J. Bivalacqua, Ashley E. Ross, George J. Netto, Alex Baras, Jong Chul Park, Carolyn Chapman, Timothy A. Masterson, Michael O. Koch, Richard Bihrle, Richard S. Foster, Thomas A. Gardner, Liang Cheng, David R. Jones, Kyle McElyea, George E. Sandusky, Timothy Breen, Ziyue Liu, Costantine Albany, Marietta L. Moore, Rhoda L. Loman, Angela Reed, Scott A. Turner, Francine B. De Abreu, Torrey Gallagher, Gregory J. Tsongalis, Elizabeth R. Plimack, Richard E. Greenberg, Daniel M. Geynisman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 3003–3011.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-2267
Published: 14 June 2017
View article
PDF
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Eric J. Small, Raymond S. Lance, Thomas A. Gardner, Lawrence I. Karsh, Lawrence Fong, Candice McCoy, Todd DeVries, Nadeem A. Sheikh, Debraj GuhaThakurta, Nancy Chang, Charles H. Redfern, Neal D. Shore
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (17): 3862–3869.
DOI: https://doi.org/10.1158/1078-0432.CCR-15-0079
Published: 31 August 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

Debraj GuhaThakurta, Nadeem A. Sheikh, Li-Qun Fan, Harini Kandadi, T. Craig Meagher, Simon J. Hall, Philip W. Kantoff, Celestia S. Higano, Eric J. Small, Thomas A. Gardner, Kate Bailey, Tuyen Vu, Todd DeVries, James B. Whitmore, Mark W. Frohlich, James B. Trager, Charles G. Drake
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (16): 3619–3630.
DOI: https://doi.org/10.1158/1078-0432.CCR-14-2334
Published: 13 August 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy

Xiong Li, You-Hong Liu, Sang-Jin Lee, Thomas A. Gardner, Meei-Huey Jeng, Chinghai Kao
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 291–299.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-0867
Published: 02 January 2008
View article
PDF
Journal Articles

Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

Xiong Li, You-Hong Liu, Yan-Ping Zhang, Shaobo Zhang, Xinzhu Pu, Thomas A. Gardner, Meei-Huey Jeng, Chinghai Kao
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5463–5473.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-0342
Published: 17 September 2007
View article
PDF